#OctoberIssue | Most rheumatic and musculoskeletal diseases fall along a spectrum of disorders from #autoinflammatory diseases to #autoimmune diseases, with ‘mixed-pattern’ diseases having features of both. Find out more in our #Review go.nature.com/3hYvrtg

Congratulations! Andrea Fava

🚨 Today #Anifrolumab has been approved in the European Union 🇪🇺 as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic #lupus erythematosus (#SLE), despite receiving standard therapy. 👍 astrazeneca.com/media-centre/p…

Neutrophil-derived Ro52 isoforms are targeted by pathogenic autoantibodies in SLE: buff.ly/3VuCv2T Eduardo Gomez Merlin Paz Alessandra Ida Celia Johns Hopkins Medicine #Immunology

🎉Congratulations to the winners of the #EMEUNETtop10abstracts at #ACR22 Lisa Christ, Alessandra Ida Celia , Shinji Izuka, Cristiana Sieiro Santos, Beatriz Samões, Fabian Proft, Marc Scherlinger, Sarah Dyball, Caoilfhionn Connolly and Julius Lindblom #RheumTwitter #eularEMEUNET

📢 Do not miss! Alessandra Ida Celia: Proteomic analysis of histological lesions in #Lupus nephritis identifies an inflammatory signature of fibrous crescents 📆 Sunday, 13 November at 9:00 SLE–etiology and pathogenesis #eularemeunet #EMEUNETtop10abstracts #ACR22

We are proud of our #EMEUNETtop10abstracts presenters, who did a great job at #ACR22 Want to know more about them? You can find all presenters and abstracts on our website Read more 👉 emeunet.eular.org/top10_abstract… #EULAR #eularEMEUNET #rheumatology #rheumatologist

Glomerulonephritis: immunopathogenesis and immunotherapy dlvr.it/Sgmj79

Thanks for being an amazing inspiration @SelenaGomez – and raising your voice about kidney-related lupus. Working together we’ve made great strides, but the LRA remains steadfast on finding new and better treatments for our community. We salute you & all #lupusnephritis warriors.

Many thanks to the LRA for supporting our research. Looking forward to bringing precision immunotherapies to lupus. 🦋 Johns Hopkins Medicine Hopkins Med News The Johns Hopkins Institute for NanoBioTechnology

💫#MakeLupusVisible! Be part of #WorldLupusDay by joining the conversation on all kind of channels! 🟣Wear your favourite purple items today. 🟣Share Lupus facts on social media. 🟣Participate in the World Lupus Day social media campaign. #EULAR #Lupus #WorldLupusDay2023

#EULAR 2023 A great pleasure to be here all together. #Sapienza #Rheumatology

Meeting #CardioTwitter Friends 🤝 at #ESCCongress 🚀 SABOURETCardiologist Mattia Galli

Honoured to receive this award! Huge thanks to Lupus Academy for the opportunity and gratitude to my mentor Andrea Fava for guiding me every step of the journey! 🙏🏻#grateful #AwardWinning

Wonderful presentation by Alessandra Ida Celia on a possibly novel cell type implicated in lupus nephritis #ACR23 #ACRBest

Urinary biomarkers precede loss of kidney function for lupus nephritis In Abstract 0850, Dr. Andrea Fava from Johns Hopkins presents research on the value of urinary biomarkers as measure of intrarenal inflammation. bit.ly/3sCWEKM

Another Great Rheumatology Roundup (#ACR23) w/ Drs. Kavanaugh & Cush. Abstr: 0025 Cannibinoids & pain 1584 TMP/SMX in GPA 0607 CAR-T cell 1583 SMART LB07 Arctic Rewind 2480 RA Flare Cutpoints 2548 Uveitis BKZ 2427 PR3+ LN 0445 TCZ biosimilars 1008 ED L03 VEXAS 1269 3 S Rule

✅ The latest KDIGO guidelines for the management of #lupus #nephritis have just been published ⬇️ This is THE reference for anyone interested in the management of #LN 👍

🔬 Exciting news in #Lupus! Our latest study is out. Discover how urinary biomarkers can transform lupus nephritis diagnosis & guide treatment. Plus novel insights into disease mechanism 🚀🚀. Dive into the research here buff.ly/48JqcGg #Rheumatology #Nephrology